Find investors
← Back to all investors
J Bowden
ResearchedAngel Investors

J Bowden

Associate

Angel InvestorsSeed Round
Pitch J

Get their honest, personalized take on your startup.

Sign in to pitch J

At a glance

Full Name
Duncan Bowden
Title
Principal
Firm
Blue Marlin Partners
Firm Type
Private investment firm / direct private equity investor
Investment Stage
Growth to mature; for Blue Marlin's AI Investment Platform, post-seed rounds including Series A, B, and C
Check Size
Blue Marlin targets $15M+ equity checks for established lower-middle-market businesses; AI platform investments are $5.0M-$20.0M initially or over time
Target Company Profile
Established, profitable lower-middle-market businesses with $5M+ EBITDA, strong fundamentals, clear growth paths, and potential to benefit from Blue Marlin's Capital Partner expertise; AI platform targets revenue-generating companies with demonstrated product-market fit
Sector Focus
Generalist across business services, consumer, energy, healthcare, industrials, and technology; AI platform focuses on vertical AI solutions in markets such as healthcare, services, and consumer
Location
Blue Marlin Partners is headquartered in Bethesda, Maryland; Wake Forest University lists Bowden in Mt. Pleasant, South Carolina

Background

Duncan Bowden is a Principal at Blue Marlin Partners, a Bethesda, Maryland-based private investment firm. Blue Marlin's model is built around direct investing with a network of high-net-worth operators and Capital Partners who help source, diligence, govern, and build portfolio companies.

Before joining Blue Marlin, Bowden was an Investment Associate at Liberty Hall Capital Partners, described by Blue Marlin as a lower-middle-market buyout firm in South Carolina. In that role, he was involved across the investment process and worked on strategic initiatives with portfolio companies.

Earlier in his career, Bowden worked in the Leveraged Finance group at Bank of America Merrill Lynch. He received a B.S. in Finance from Wake Forest University; Wake Forest University's School of Business alumni council lists him as Class of 2017 and affiliated with Blue Marlin Partners.

Investment Thesis & Focus

  • Blue Marlin targets "established, profitable lower middle market businesses with strong fundamental performance, clear growth paths, and potential to leverage the expertise of our Capital Partners."
  • The firm's investment process emphasizes direct investing, rigorous diligence, and active post-closing support through board representation, management consultation, and business improvement initiatives.
  • Blue Marlin's standard investment criteria include $5M+ EBITDA, $15M+ equity check size, growth-to-mature stage companies, and a preference for direct/control investments while remaining open to minority and co-investments.
  • The firm is sector-generalist but prioritizes areas where its management team, advisors, and Capital Partners have relevant expertise.
  • For AI, Blue Marlin's platform focuses on revenue-generating, post-seed companies applying AI to real-world business challenges for middle-market customers, especially vertical or function-specific solutions with proprietary data and measurable customer outcomes.

Notable Investments

  • Confluent Health: Healthcare services company focused on physical and occupational therapy; Blue Marlin made a co-investment in December 2016 and realized it in June 2019.
  • DataBank: Enterprise data center, cloud, and interconnection services provider; Blue Marlin lists co-investments in March 2017, realized December 2019, and December 2020.
  • Rensa Filtration: Manufacturer of commercial and industrial air-filtration products; Blue Marlin made a co-investment in December 2017 and realized it in August 2022.
  • Ethermed: AI Investment Platform portfolio company; Blue Marlin announced the platform's first investment in November 2025.
  • Teletrac Navman: Fleet-management and connected-vehicle technology company; Blue Marlin announced its acquisition in June 2026.
  • Deerfield Group: Blue Marlin announced the sale of this portfolio company in July 2026.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.